Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Pharmaceutical Statistics
|
April 19, 2026
A Dose-Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D-Optimality
Maxine Ajimi, Benjamin Webb, Graham M Wheeler, et al.
JCO Precision Oncology
|
January 5, 2024
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects
Zhulin Yin, Adrian P Mander, Johann S de Bono, et al.
Pharmaceutical Statistics
|
January 11, 2012
Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis
Adrian P Mander, James M S Wason, Michael J Sweeting, et al.
International Journal of Obesity (2005)
|
October 4, 2007
A prospective analysis of dietary energy density at age 5 and 7 years and fatness at 9 years among UK children
L Johnson, A P Mander, L R Jones, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
July 10, 2007
Is sugar-sweetened beverage consumption associated with increased fatness in children?
Laura Johnson, Adrian P Mander, Louise R Jones, et al.
The American Journal of Clinical Nutrition
|
April 11, 2008
Energy-dense, low-fiber, high-fat dietary pattern is associated with increased fatness in childhood
Laura Johnson, Adrian P Mander, Louise R Jones, et al.
Plos One
|
February 21, 2015
Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis
Zoe Tolkien, Lynne Stecher, Adrian P Mander, et al.
Nature Reviews. Clinical Oncology
|
March 20, 2013
Adaptive designs for dual-agent phase I dose-escalation studies
Jennifer A Harrington, Graham M Wheeler, Michael J Sweeting, et al.
Statistics in Medicine
|
February 20, 2016
Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration
Graham M Wheeler, Michael J Sweeting, Adrian P Mander, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
October 7, 2009
No difference in the 24-hour interstitial fluid glucose profile with modulations to the glycemic index of the diet
Louise M Aston, Roberta Laccetti, Adrian P Mander, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Pharmaceutical Statistics
|
April 19, 2026
A Dose-Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D-Optimality
Maxine Ajimi, Benjamin Webb, Graham M Wheeler, et al.
JCO Precision Oncology
|
January 5, 2024
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects
Zhulin Yin, Adrian P Mander, Johann S de Bono, et al.
Pharmaceutical Statistics
|
January 11, 2012
Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis
Adrian P Mander, James M S Wason, Michael J Sweeting, et al.
International Journal of Obesity (2005)
|
October 4, 2007
A prospective analysis of dietary energy density at age 5 and 7 years and fatness at 9 years among UK children
L Johnson, A P Mander, L R Jones, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
July 10, 2007
Is sugar-sweetened beverage consumption associated with increased fatness in children?
Laura Johnson, Adrian P Mander, Louise R Jones, et al.
The American Journal of Clinical Nutrition
|
April 11, 2008
Energy-dense, low-fiber, high-fat dietary pattern is associated with increased fatness in childhood
Laura Johnson, Adrian P Mander, Louise R Jones, et al.
Plos One
|
February 21, 2015
Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis
Zoe Tolkien, Lynne Stecher, Adrian P Mander, et al.
Nature Reviews. Clinical Oncology
|
March 20, 2013
Adaptive designs for dual-agent phase I dose-escalation studies
Jennifer A Harrington, Graham M Wheeler, Michael J Sweeting, et al.
Statistics in Medicine
|
February 20, 2016
Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration
Graham M Wheeler, Michael J Sweeting, Adrian P Mander, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
October 7, 2009
No difference in the 24-hour interstitial fluid glucose profile with modulations to the glycemic index of the diet
Louise M Aston, Roberta Laccetti, Adrian P Mander, et al.
Page
of 9